SCHEMBL63055

SCHEMBL63055

COC(=O)C=Cc1ccccc1O

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 5/20 0.65
ALDH1A1 P00352 2/20 0.65
KDM4E B2RXH2 2/20 0.65
MEN1 O00255 1/20 0.65
TP53 P04637 1/20 0.65
CYP1A2 P05177 1/20 0.65
CYP2C9 P11712 1/20 0.65
HPGD P15428 1/20 0.65
ALOX15 P16050 1/20 0.65
CYP2C19 P33261 1/20 0.65
KMT2A Q03164 1/20 0.65
HSD17B10 Q99714 1/20 0.65
LMNA P02545 1/20 0.65
NFKB1 P19838 2/20 0.63
NFE2L2 Q16236 2/20 0.63
JUN P05412 1/20 0.63
CA1 P00915 2/20 0.61
CA2 P00918 2/20 0.61
CA4 P22748 1/20 0.61
MAPK1 P28482 2/20 0.61

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29362833 1.00 MAPT (0.65) MAPTALDH1A1KDM4EMEN1TP53
SCHEMBL63054 1.00 MAPT (0.65) MAPTALDH1A1KDM4EMEN1TP53
SCHEMBL10438847 0.88 ALDH1A1 (0.58) MAPTALDH1A1KDM4EMEN1TP53
SCHEMBL69522 0.88 ALDH1A1 (0.58) MAPTALDH1A1KDM4EMEN1TP53
SCHEMBL11061667 0.86 ALDH1A1 (0.56) MAPTALDH1A1KDM4EMEN1TP53
SCHEMBL2933196 0.86 IAPP (0.67) MAPTALDH1A1KDM4EMEN1TP53
SCHEMBL2933198 0.86 IAPP (0.67) MAPTALDH1A1KDM4EMEN1TP53
SCHEMBL28343398 0.85 NFKB1 (0.68) MAPTKDM4ELMNANFKB1NFE2L2
SCHEMBL30673968 0.85 NFKB1 (0.68) MAPTKDM4ELMNANFKB1NFE2L2
SCHEMBL7108533 0.84 MAPT (0.55) MAPTALDH1A1KDM4EMEN1TP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 76 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109401605-A Thermosetting composition, cured film and colored filter 捷恩智株式会社 2019-03-01 CN claimed
US-3998851-A PREPARATION OF COUMARINS UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-12-21 US claimed
US-20250188023-A1 BENZENE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2025-06-12 US disclosed
EP-4545512-A1 NOVEL CINNAMAMIDE DERIVATIVE AND USE THEREOF Korea Research Institute of Bioscience and Biotechnology (KR) 2025-04-30 EP disclosed
CN-119731151-A Novel cinnamide derivative and use thereof 韩国生命工学研究院 2025-03-28 CN disclosed
US-12258308-B2 Benzene derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2025-03-25 US disclosed
US-20250082620-A1 NOVEL CINNAMAMIDE DERIVATIVES AND USE THEREOF KOREA RESEARCH INSTITUTE OF BIOSCIENCE AND BIOTECHNOLOGY (KR) 2025-03-13 US disclosed
WO-2023249288-A1 NOVEL CINNAMAMIDE DERIVATIVE AND USE THEREOF 한국생명공학연구원 2023-12-28 WO disclosed
CN-112513011-B Benzene derivatives 小野药品工业株式会社 2023-06-16 CN disclosed
US-20220089532-A1 BENZENE DERIVATIVE ONO PHARMACEUTICAL CO., LTD. (JP) 2022-03-24 US disclosed
US-11261154-B2 Benzene derivative ONO PHARMACEUTICAL CO., LTD. (JP) 2022-03-01 US disclosed
US-4906661-A Esters of aryloxypropanolamine derivatives E. I. DU PONT DE NEMOURS AND COMPANY (US) 1990-03-06 US disclosed
US-4804677-A CARDIOTONIC AGENTS; GLAUCOMA; SIDE-EFFECT REDUCTION E. I. DU PONT DE NEMOURS AND COMPANY (US) 1989-02-14 US disclosed
US-4692446-A ADRENERGIC BLOCKING AGENTS E. I. DU PONT DE NEMOURS & CO., INC. (US) 1987-09-08 US disclosed
US-4623652-A ADRENERGIC BLOCKING AGENTS AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1986-11-18 US disclosed
EP-0093155-B1 ESTERS OF ARYLOXYPROPANOLAMINE DERIVATIVES AND USE AS BETA-ADRENERGIC BLOCKING AGENTS AMERICAN HOSPITAL SUPPLY CORPORATION (US) 1986-08-27 EP disclosed
EP-0093155-A4 ESTERS OF ARYLOXYPROPANOLAMINE DERIVATIVES AND USE AS BETA-ADRENERGIC BLOCKING AGENTS. AMERICAN HOSPITAL SUPPLY CORP (US) 1984-04-24 EP disclosed
EP-0093155-A1 ESTERS OF ARYLOXYPROPANOLAMINE DERIVATIVES AND USE AS BETA-ADRENERGIC BLOCKING AGENTS. AMERICAN HOSPITAL SUPPLY CORP (US) 1983-11-09 EP disclosed
WO-1983001772-A1 ESTERS OF ARYLOXYPROPANOLAMINE DERIVATIVES AND USE AS 'beta'-ADRENERGIC BLOCKING AGENTS AMERICAN HOSPITAL SUPPLY CORP (US) 1983-05-26 WO disclosed
US-3998851-A PREPARATION OF COUMARINS UNIVERSAL OIL PRODUCTS COMPANY (US) 1976-12-21 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250082620-A1 NOVEL CINNAMAMIDE DERIVATIVES AND USE THEREOF CCAR2, ATF4, CREBBP MAPT 4323/4885ALDH1A1 110/4885KDM4E 2304/4885
US-12258308-B2 Benzene derivative PMP22, TMBIM6, MYT1 MAPT 2169/4885ALDH1A1 1189/4885KDM4E 2022/4885
US-11261154-B2 Benzene derivative PMP22, TMBIM6, MYT1 MAPT 2169/4885ALDH1A1 1189/4885KDM4E 2022/4885
US-20250188023-A1 BENZENE DERIVATIVE PMP22, TMBIM6, MYT1 MAPT 2085/4885ALDH1A1 1203/4885KDM4E 1914/4885
US-20220089532-A1 BENZENE DERIVATIVE PMP22, TMBIM6, MYT1 MAPT 2169/4885ALDH1A1 1189/4885KDM4E 2022/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.